Soluble receptor BR43x2 and methods of using

Soluble receptor BR43x2 and methods of using

  • CN 101,518,648 A
  • Filed: 01/07/2000
  • Published: 09/02/2009
  • Est. Priority Date: 01/07/1999
  • Status: Abandoned Application
First Claim
Patent Images

1. in mammal, suppress the active method of ztnf4, comprise to a certain amount of chemical compound that is selected from down group of described administration:

  • A) contain the polypeptide of the extracellular domain of BR43 * 2;

    B) contain the polypeptide of the extracellular domain of TACI;

    C) contain the polypeptide of the extracellular domain of BCMA;

    D) contain the polypeptide of sequence of SEQ ID NO;

    10;

    E) with the antibody or the antibody fragment of the polypeptide specific bond of SEQ ID NO;

    2;

    F) with the antibody or the antibody fragment of the polypeptide specific bond of SEQ ID NO;

    4;

    G) with the antibody or the antibody fragment of the polypeptide specific bond of SEQ ID NO;

    6;

    H) with the antibody or the antibody fragment of the polypeptide specific bond of SEQ ID NO;

    8;

    I) with the antibody or the antibody fragment of the polypeptide specific bond of SEQ ID NO;

    10;

    K) polypeptide of SEQ ID NO;

    4;

    L) the 1-166 amino acids residue of SEQ ID NO;

    6;

    WithM) the 1-150 amino acids residue of SEQ ID NO;

    8.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×